Skip to main content
Clinical Trials/NCT04885582
NCT04885582
Completed
Not Applicable

The Relationship Between HLA Tissue Compatibility and Biliary Complications in Patients With Liver Transplantation

Inonu University1 site in 1 country80 target enrollmentMay 10, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Transplant; Complications
Sponsor
Inonu University
Enrollment
80
Locations
1
Primary Endpoint
Bliary complications
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Liver transplantation has become the accepted treatment option for advanced liver failure in recent years. In addition to the increase in the number of centers performing transplant and the decrease in complication rates depending on the experience gained, the most common biliary complications did not improve at the desired level. For this reason, studies in this field are frequent today.

The structural complexities of HLA antigens have been the subject of investigation in recent years. With the development of DNA and RNA amplification methods; It is increasingly difficult for physicians to keep up with the increasing burden of knowledge regarding the genetic aspects of these antigens. Concrete benefits of this gene complex, which has been investigated in various fields and preserves its mystery, have not been determined in liver transplant patients. However, there are publications showing its connection with the bile epithelium in liver transplantation and its relationship with the disappearing bile duct syndrome. In this study, our aim is to explain whether the bile duct complications, which appear like a continuous wall and can lead to frightening pictures, are related to HLA tissue compatibility.

Registry
clinicaltrials.gov
Start Date
May 10, 2017
End Date
May 20, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ersin Gündoğan

Assoc Prof

Inonu University

Eligibility Criteria

Inclusion Criteria

  • patients with liver transplantation and tested for HLA antigen (recipient - donor)

Exclusion Criteria

  • patients who died early Patients whose HLA antigen is not checked

Outcomes

Primary Outcomes

Bliary complications

Time Frame: 2 years

Biliary fistüla, biliary stenosis

Study Sites (1)

Loading locations...

Similar Trials